AN2 Therapeutics
our global health commitment global health agreement partners an leadership team is committed to applying our know how to help solve some of the infections in global health intent is to fund these efforts primarily through non dilutive funding from sources such as public and private agencies and foundations the highest priority is currently conducting preclinical research with an university an therapeutics | AN2 Therapeutics
Deck date
August 2022
Slide
23 of 25
Similar slides by AN2 Therapeutics
IPO
March 2022
Related slides by other companies
Start Up
October 2014
Investor Presentation
January 2024
Investor Conference
August 2022
Results
August 2021
Other recent decks by AN2 Therapeutics
IPO
March 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io